Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. by Danila, D, Heller, G, Gignac, G, Gonzalez-Espinoza, R, Anand, A, Tanaka, E, Lilja, H, Schwartz, L, Larson, S, Fleisher, M, Scher, H

Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer. by Leversha, M, Han, J, Asgari, Z, Danila, D, Lin, O, Gonzalez-Espinoza, R, Anand, A, Lilja, H, Heller, G, Fleisher, M, Scher, H

Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer. by Shaffer, DR, Leversha, M, Danila, D, Lin, O, Gonzalez-Espinoza, R, Gu, B, Anand, A, Smith, K, Maslak, P, Doyle, G, Terstappen, L, Lilja, H, Heller, G, Fleisher, M, Scher, H

Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and associa... by Helo, P, Cronin, A, Danila, D, Wenske, S, Gonzalez-Espinoza, R, Anand, A, Koscuiszka, M, Väänänen, R, Pettersson, K, Chun, F, Steuber, T, Huland, H, Guillonneau, B, Eastham, J, Scardino, P, Fleisher, M, Scher, H, Lilja, H